Zhongnan Medical Journal Press

Home Results

A total of 15 result was found. Results that relate to AN Wei

Research progress in antibacterial modification of titanium implant surface

Published on New Medicine 2023,33(1):50-61.
11720 times 3941 times

Yong-Han WEI Yu-Jie SHI Wan-Qi PENG Wen-Zhong XIE Ling-Ling ZHANG Jun SHAO

Titanium implants Antibacterial modification Nanostructures Anti-adhesion Contact sterilization
Details
Observation of the therapeutic effect of Liuwei Dihuang decoction on thrombocytopenia of liver and kidney yin deficiency in hemodialysis patients

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1354-1361.
9433 times 2005 times

Rong CAO Hua-Juan WEI Shan-Shan SUN Na QIN Wei-Hua LIU Li-Yan SUN

Liuwei Dihuang decoction Hemodialysis Liver and kidney Yin deficiency Thrombocytopenia Clinical efficacy Platelet count
Details
A case of pharmaceutical caring for psychiatric abnormalities associated with low dose regorafenib in the treatment of advanced soft tissue sarcoma

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):466-470.
8835 times 1835 times

FANG Shasha AN Wei TIAN Ying YU Qianqian ZHANG Mingwei CHEN Min

Regorafenib Soft tissue sarcoma Mental disorders Drug adverse reactions Pharmaceutical care
Details
Efficacy and safety of trastuzumab deruxtecan in the treatment of breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):539-548.
8314 times 1905 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details
Status of etiology and pathogenesis of lumbar ligamentum flavum hypertrophy

Published on Journal of Mathematical Medicine 2024,37(7):534-542.
11823 times 2228 times

MAO Jianwei [MW ZHANG Weiping YANG Chen LI Jingzhou QIANG Tianming DUAN Wenshuai

Ligamentum flavum hypertrophy Fibrosis Etiology Pathogenesis
Details
Signal mining and analysis of adverse drug events related to trastuzumab emtansine and trastuzumab deruxtecan based on JADER database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):841-850.
9550 times 1831 times

PAN Weiping YAN Shaowei LI Binghuang CAO Yu XU Wentan

Trastuzumab emtansine Trastuzumab deruxtecan Adverse drug event JADER database Pharmacovigilance Antibody-drug conjugates
Details
Construction of a prediction model for moderate to severe perimenopausal syndrome based on machine learning algorithms

Published on New Medicine 2024,34(8):871-879.
8937 times 1976 times

ZHANG Min GU Tingting GUAN Wei LIU Xiangxiang SHI Junyao

Perimenopausal syndrome Perimenopausal women Machine learning Prediction
Details
Evaluation of potentially inappropriate medication of novel oral anticoagulant in elderly patients with non-valvular atrial fibrillation

Published on Chinese Journal of Pharmacoepidemiology 2025,34(1):21-26.
8430 times 1133 times

WANG Yan TIAN Weiwei ZHU Haibin YU Zicheng

Novel oral anticoagulants Elderly patient Non-valvular atrial fibrillation Potential inappropriate medication
Details
Practice and reflection on the compliance construction of WHO pharmaceutical microbiology quality control laboratory

Published on Frontiers in Pharmaceutical Sciences 2025,29(5):894-900.
6299 times 898 times

PAN Weijing PENG Ming WU Xiaoluan QIN Feng GU Songqing

World Health Organization Pharmaceutical microbiology Quality control laboratory Compliance construction
Details
Clinical progress of cadonilimab in the treatment of malignant tumor

Published on New Medicine 2025,35(6):708-715.
10675 times 1820 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai WANG Yuchao HE Jing LUAN Wei

Cadonilimab Bispecific antibody Immunotherapy Tumors
Details
Commercial specification standards and quality evaluation of Ginseng Radix et Rhizoma Rubra

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1303-1313.
4306 times 774 times

FAN Weixu SUN Baohui HOU Fangjie

Ginseng Radix et Rhizoma Rubra Specifications Grades Quality evaluation
Details
Progress of gut microbiota in tumor immunotherapy

Published on New Medicine 2025,35(9):1099-1107.
6050 times 671 times

ZHANG Xiaoqing SU Rina LIU Shuai ZHANG Kai HE Jing WANG Yuchao LUAN Wei

Gut microbiota Immune system Immune checkpoint inhibitors Tumour therapy
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1198-1205.
3327 times 585 times

CHEN Lingbin PAN Weiping CHEN Zhou XU Wentan

Inclisiran Dyslipidemia Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Bibliometric analysis of research status and hotspots in the field of the disassembled prescription of traditional Chinese medicine compound

Published on Journal of Mathematical Medicine 2025,38(10):744-755.
2810 times 570 times

TAN Wei HUO Shengxia WU Chunxing LI Hanglin

Traditional Chinese medicine compound Disassembled prescription Bibliometrics CiteSpace VOSviewer Mechanisms
Details
Association with PM2.5 exposure and metabolic syndrome: a cross-sectional study in rural areas in three provinces of China

Published on New Medicine 2025,35(12):1387-1397.
3484 times 675 times

JI Qingyuan ZHANG Hanbin YE Pengpeng LIU Tingzhuo DU Xue WANG Tengyi LI Xiaoying TIAN Wei ZHANG Xinyi TIAN Maoyi

Metabolic syndrome Particulate matter 2.5 Indoor air monitoring Rural China Cross-sectional study
Details